BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20960291)

  • 1. In vivo kinetics and biodistribution of a Hantaan virus DNA vaccine after intramuscular injection in mice.
    Wang S; Nie Q; Zheng LY; Hu J; Luo EJ
    Virol Sin; 2010 Jun; 25(3):177-82. PubMed ID: 20960291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and risk evaluation of DNA vaccine against Schistosoma japonicum.
    Liu HF; Li W; Lu MB; Yu LJ
    Parasitol Res; 2013 Jan; 112(1):59-67. PubMed ID: 22990210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for haemorrhagic fever with renal syndrome delivered by intramuscular electroporation.
    Hooper JW; Moon JE; Paolino KM; Newcomer R; McLain DE; Josleyn M; Hannaman D; Schmaljohn C
    Clin Microbiol Infect; 2014 May; 20 Suppl 5():110-7. PubMed ID: 24447183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodistribution of DNA plasmid vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile virus is similar, without integration, despite differing plasmid backbones or gene inserts.
    Sheets RL; Stein J; Manetz TS; Duffy C; Nason M; Andrews C; Kong WP; Nabel GJ; Gomez PL
    Toxicol Sci; 2006 Jun; 91(2):610-9. PubMed ID: 16569729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin.
    McCoy JR; Mendoza JM; Spik KW; Badger C; Gomez AF; Schmaljohn CS; Sardesai NY; Broderick KE
    Hum Vaccin Immunother; 2015; 11(3):746-54. PubMed ID: 25839221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin.
    McCoy JR; Mendoza JM; Spik KW; Badger C; Gomez AF; Schmaljohn CS; Sardesai NY; Broderick KE
    Hum Vaccin Immunother; 2014; 10(10):3039-47. PubMed ID: 25483486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inoculation of plasmids encoding Japanese encephalitis virus PrM-E proteins with colloidal gold elicits a protective immune response in BALB/c mice.
    Zhao Z; Wakita T; Yasui K
    J Virol; 2003 Apr; 77(7):4248-60. PubMed ID: 12634382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA immunization of mice and macaques with plasmids encoding hepatitis C virus envelope E2 protein expressed intracellularly and on the cell surface.
    Forns X; Emerson SU; Tobin GJ; Mushahwar IK; Purcell RH; Bukh J
    Vaccine; 1999 Apr; 17(15-16):1992-2002. PubMed ID: 10217599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with a DNA expression vector encoding the varicella zoster virus glycoprotein E (gE) gene via intramuscular and subcutaneous routes.
    Hasan UA; Harper DR; Argent S; Layton G; Wren BW; Morrow WJ
    Vaccine; 2000 Feb; 18(15):1506-14. PubMed ID: 10618548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semliki Forest virus-based vaccines: persistence, distribution and pathological analysis in two animal systems.
    Morris-Downes MM; Phenix KV; Smyth J; Sheahan BJ; Lileqvist S; Mooney DA; Liljeström P; Todd D; Atkins GJ
    Vaccine; 2001 Feb; 19(15-16):1978-88. PubMed ID: 11228368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of recombinant adenovirus type 5, vaccinia virus, modified vaccinia ankara virus, and DNA antigen expression in vivo and the induction of memory T-lymphocyte responses.
    Geiben-Lynn R; Greenland JR; Frimpong-Boateng K; Letvin NL
    Clin Vaccine Immunol; 2008 Apr; 15(4):691-6. PubMed ID: 18272665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of Hantaan virus-specific immune responses in C57BL/6 mice by immunization with a modified recombinant adenovirus containing the chimeric gene, GcS0.7.
    Li K; Li PY; Wu XA; Zhang L; Liu ZY; Yu L; Zhang L; Cheng LF; Bai WT; Zhang FL; Xu ZK
    Int J Mol Med; 2013 Sep; 32(3):709-16. PubMed ID: 23783439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasal absorption and biodistribution of plasmid DNA: an alternative route of DNA vaccine delivery.
    Oh YK; Kim JP; Hwang TS; Ko JJ; Kim JM; Yang JS; Kim CK
    Vaccine; 2001 Aug; 19(31):4519-25. PubMed ID: 11483279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunization with targeted fusion anticaries DNA vaccine via intramuscular route:experiment with murine].
    Yu F; Fan MW; Xu QA; Jia R; Guo JH; Bian Z; Chen Z; Peng B; Fan B
    Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):754-9. PubMed ID: 15200917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine granulocyte-macrophage colony-stimulating factor expressed from a bicistronic simian immunodeficiency virus-based integrase-defective lentiviral vector does not enhance T-cell responses in mice.
    Michelini Z; Negri D; Biava M; Baroncelli S; Spada M; Leone P; Bona R; Blasi M; Nègre D; Klotman ME; Cara A
    Viral Immunol; 2014 Dec; 27(10):512-20. PubMed ID: 25343523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A DNA vaccine against foot-and-mouth disease elicits an immune response in swine which is enhanced by co-administration with interleukin-2.
    Wong HT; Cheng SC; Sin FW; Chan EW; Sheng ZT; Xie Y
    Vaccine; 2002 Jun; 20(21-22):2641-7. PubMed ID: 12034088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hantavirus-like particles generated in CHO cells induce specific immune responses in C57BL/6 mice.
    Li C; Liu F; Liang M; Zhang Q; Wang X; Wang T; Li J; Li D
    Vaccine; 2010 Jun; 28(26):4294-300. PubMed ID: 20433802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and characterization of a replication-competent human adenovirus type 3-based vector as a live-vaccine candidate and a viral delivery vector.
    Zhang Q; Su X; Seto D; Zheng BJ; Tian X; Sheng H; Li H; Wang Y; Zhou R
    Vaccine; 2009 Feb; 27(8):1145-53. PubMed ID: 19146906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with a DNA vaccine encoding Toxoplasma gondii Superoxide dismutase (TgSOD) induces partial immune protection against acute toxoplasmosis in BALB/c mice.
    Liu Y; Cao A; Li Y; Li X; Cong H; He S; Zhou H
    BMC Infect Dis; 2017 Jun; 17(1):403. PubMed ID: 28592247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Protective efficacy of co-immunization with Sj26 DNA and recombinant protein vaccine against Schistosoma japonicum in mice].
    Yu GQ; Liu WQ; Lei JH; Mo HM; Chen YL; Li YL
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Feb; 24(1):51-5. PubMed ID: 16866145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.